Skip to main content
. 2021 Jul 6;9:670108. doi: 10.3389/fpubh.2021.670108

Table 6.

Base case analysis results.

Absolute Incremental Absolute Incremental
PER 8 mg/day LCM 400 mg/day Change% PER 4 mg/day LCM 200 mg/day Change%
Seizures 467 608 −141 −23.22 717 789 −72 −9.14
LYs 4.940 4.879 0.061 1.26 5.17 5.158 0.012 0.24
QALYs 3.137 3.083 0.054 1.75 3.278 3.268 0.010 0.31
Drug costs 9,144 11,462 −23,18 −20.22 7,304 8,229 −925 −11.24
Medical costs 7,001 7,073 −72 −1.01 7,400 7,335 65 0.89
Total costs 16,145 18,535 −2,390 −12.89 14,704 15,564 −860 −5.52

PER, perampanel; LCM, lacosamide; LY, life year; QALY, quality-adjusted life years.